Neurologic indications for therapeutic plasma exchange: 2013 update

J Clin Apher. 2014 Aug;29(4):211-9. doi: 10.1002/jca.21331. Epub 2014 May 31.

Abstract

Neurologists commonly use therapeutic plasma exchange (TPE) to treat a number of conditions. This concise review considers the most common neurologic indications for TPE. It focuses on Guillain-Barré syndrome and myasthenia gravis and also the role of TPE in chronic inflammatory demyelinating polyneuropathy, Lambert-Eaton syndrome, multiple sclerosis, neuromyelitis optica, paraproteinemic polyneuropathy, Sydenham's chorea, and natalizumab-associated progressive multifocal leukoencephalopathy. As with any treatment, the proven efficacy, cost, side effects, and availability must be considered before initiation of therapy.

Keywords: CIDP; Guillain-Barré syndrome; Lambert-Eaton syndrome; Syndenham's chorea; apheresis; myasthenia gravis; natalizumab; neurologic indications; plasmapheresis; progressive multifocal leukoencephalopathy.

Publication types

  • Review

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Autoimmune Diseases of the Nervous System / immunology
  • Autoimmune Diseases of the Nervous System / therapy*
  • Combined Modality Therapy
  • Dyskinesias / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Leukoencephalopathy, Progressive Multifocal / chemically induced
  • Leukoencephalopathy, Progressive Multifocal / therapy
  • Natalizumab
  • Paraproteinemias / therapy
  • Plasma Exchange*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents
  • Natalizumab